Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

The Histomorphology of Lynch Syndrome-associated Ovarian Carcinomas: Toward a Subtype-specific Screening Strategy.

Chui MH, Ryan P, Radigan J, Ferguson SE, Pollett A, Aronson M, Semotiuk K, Holter S, Sy K, Kwon JS, Soma A, Singh N, Gallinger S, Shaw P, Arseneau J, Foulkes WD, Gilks CB, Clarke BA.

Am J Surg Pathol. 2014 Sep;38(9):1173-81. doi: 10.1097/PAS.0000000000000298.

PMID:
25025451
[PubMed - in process]
2.

Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.

Ryan P, Mulligan AM, Aronson M, Ferguson SE, Bapat B, Semotiuk K, Holter S, Kwon J, Kalloger SE, Gilks CB, Gallinger S, Pollett A, Clarke BA.

Cancer. 2012 Feb 1;118(3):681-8. doi: 10.1002/cncr.26323. Epub 2011 Jun 30.

PMID:
21721000
[PubMed - indexed for MEDLINE]
Free Article
3.

Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.

Jensen KC, Mariappan MR, Putcha GV, Husain A, Chun N, Ford JM, Schrijver I, Longacre TA.

Am J Surg Pathol. 2008 Jul;32(7):1029-37. doi: 10.1097/PAS.0b013e31816380c4.

PMID:
18469706
[PubMed - indexed for MEDLINE]
4.

Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.

Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, Chen LM.

Am J Surg Pathol. 2014 Jun;38(6):793-800. doi: 10.1097/PAS.0000000000000177.

PMID:
24503759
[PubMed - indexed for MEDLINE]
5.

Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.

Aysal A, Karnezis A, Medhi I, Grenert JP, Zaloudek CJ, Rabban JT.

Am J Surg Pathol. 2012 Feb;36(2):163-72. doi: 10.1097/PAS.0b013e31823bc434.

PMID:
22189970
[PubMed - indexed for MEDLINE]
6.

Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.

Casey MJ, Bewtra C, Lynch HT, Snyder C, Stacy M, Watson P.

Fam Cancer. 2013 Dec;12(4):719-40. doi: 10.1007/s10689-013-9651-x.

PMID:
23666231
[PubMed - indexed for MEDLINE]
7.

Lynch Syndrome Screening Should Be Considered for All Patients With Newly Diagnosed Endometrial Cancer.

Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA.

Am J Surg Pathol. 2014 Sep 16. [Epub ahead of print]

PMID:
25229768
[PubMed - as supplied by publisher]
8.

Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.

Garg K, Leitao MM Jr, Kauff ND, Hansen J, Kosarin K, Shia J, Soslow RA.

Am J Surg Pathol. 2009 Jun;33(6):925-33. doi: 10.1097/PAS.0b013e318197a046.

PMID:
19238076
[PubMed - indexed for MEDLINE]
9.

Lynch syndrome-associated colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach.

Hartman DJ, Brand RE, Hu H, Bahary N, Dudley B, Chiosea SI, Nikiforova MN, Pai RK.

Hum Pathol. 2013 Nov;44(11):2518-28. doi: 10.1016/j.humpath.2013.06.012. Epub 2013 Sep 10.

PMID:
24034859
[PubMed - indexed for MEDLINE]
10.

Lynch Syndrome.

Kohlmann W, Gruber SB.

In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2014.
2004 Feb 05 [updated 2014 May 22].

PMID:
20301390
[PubMed]
Books & Documents
11.

BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome.

Toon CW, Walsh MD, Chou A, Capper D, Clarkson A, Sioson L, Clarke S, Mead S, Walters RJ, Clendenning M, Rosty C, Young JP, Win AK, Hopper JL, Crook A, von Deimling A, Jenkins MA, Buchanan DD, Gill AJ.

Am J Surg Pathol. 2013 Oct;37(10):1592-602. doi: 10.1097/PAS.0b013e31828f233d.

PMID:
23797718
[PubMed - indexed for MEDLINE]
12.

Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary.

Vierkoetter KR, Ayabe AR, VanDrunen M, Ahn HJ, Shimizu DM, Terada KY.

Gynecol Oncol. 2014 Aug 2. pii: S0090-8258(14)01223-2. doi: 10.1016/j.ygyno.2014.07.100. [Epub ahead of print]

PMID:
25093288
[PubMed - as supplied by publisher]
13.

Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.

Garg K, Shih K, Barakat R, Zhou Q, Iasonos A, Soslow RA.

Am J Surg Pathol. 2009 Dec;33(12):1869-77. doi: 10.1097/PAS.0b013e3181bc9866.

PMID:
19898223
[PubMed - indexed for MEDLINE]
14.

Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor subtype.

Chui MH, Gilks CB, Cooper K, Clarke BA.

Adv Anat Pathol. 2013 Nov;20(6):378-86. doi: 10.1097/PAP.0b013e3182a92cf8. Review.

PMID:
24113308
[PubMed - indexed for MEDLINE]
15.

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.

Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A.

J Clin Oncol. 2008 Dec 10;26(35):5783-8. doi: 10.1200/JCO.2008.17.5950. Epub 2008 Sep 22.

PMID:
18809606
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.

Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA, Smith LD, Jennings K, Grubb G, Royce SG, Walsh MD, Barker MA, Young JP, Jass JR, St John DJ, Macrae FA, Giles GG, Hopper JL.

J Clin Oncol. 2005 Sep 20;23(27):6524-32. Epub 2005 Aug 22.

PMID:
16116158
[PubMed - indexed for MEDLINE]
Free Article
17.

Screening for Germline Mismatch Repair Mutations Following Diagnosis of Sebaceous Neoplasm.

Everett JN, Raymond VM, Dandapani M, Marvin M, Kohlmann W, Chittenden A, Koeppe E, Gustafson SL, Else T, Fullen DR, Johnson TM, Syngal S, Gruber SB, Stoffel EM.

JAMA Dermatol. 2014 Jul 9. doi: 10.1001/jamadermatol.2014.1217. [Epub ahead of print]

PMID:
25006859
[PubMed - as supplied by publisher]
18.

Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas.

Niskakoski A, Kaur S, Renkonen-Sinisalo L, Lassus H, Järvinen HJ, Mecklin JP, Bützow R, Peltomäki P.

Int J Cancer. 2013 Dec 1;133(11):2596-608. doi: 10.1002/ijc.28287. Epub 2013 Jun 21.

PMID:
23716351
[PubMed - indexed for MEDLINE]
19.

Population-based screening for Lynch syndrome in Western Australia.

Schofield L, Grieu F, Amanuel B, Carrello A, Spagnolo D, Kiraly C, Pachter N, Goldblatt J, Platell C, Levitt M, Stewart C, Salama P, Ee H, Raftopoulous S, Katris P, Threlfall T, Edkins E, Wallace M, Iacopetta B.

Int J Cancer. 2014 Sep 1;135(5):1085-91. doi: 10.1002/ijc.28744. Epub 2014 Feb 24.

PMID:
24474394
[PubMed - indexed for MEDLINE]
20.

Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors.

Lu FI, Gilks CB, Mulligan AM, Ryan P, Allo G, Sy K, Shaw PA, Pollett A, Clarke BA.

Int J Gynecol Pathol. 2012 Nov;31(6):524-31. doi: 10.1097/PGP.0b013e31824fe2aa.

PMID:
23018216
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk